These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11161400)

  • 1. Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.
    Arnold JM; Mok SC; Purdie D; Chenevix-Trench G
    Br J Cancer; 2001 Feb; 84(3):352-9. PubMed ID: 11161400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
    Arnold JM; Cummings M; Purdie D; Chenevix-Trench G
    Br J Cancer; 2001 Nov; 85(9):1351-8. PubMed ID: 11720474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells.
    Shepherd TG; Thériault BL; Nachtigal MW
    Gene; 2008 May; 414(1-2):95-105. PubMed ID: 18372118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of p51 alteration in human ovarian cancer.
    Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
    Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
    Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
    Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
    Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
    Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
    Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
    Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells.
    Eickhoff B; Rüller S; Laue T; Köhler G; Stahl C; Schlaak M; van der Bosch J
    Biol Chem; 2000 Feb; 381(2):107-12. PubMed ID: 10746741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of human ovarian carcinoma cell lines.
    Yuan Y; Kim WH; Han HS; Lee JH; Park HS; Chung JK; Kang SB; Park JG
    Gynecol Oncol; 1997 Sep; 66(3):378-87. PubMed ID: 9299249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.